TRUMY News and Press, Terumo Corp. ADR From 11/01/22

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography PR Newswire –  Researchers used Terumo Health Outcomes' ePRISM®...

Summary Both Terumo and Johnson & Johnson are diversified members of the healthcare industry but with two opposite outlooks. Johnson & Johnson’s Q3 earnings highlighted the damaging effects of a strong dollar, regardless of the rebound in healthcare spending after t...

MicroVention Celebrates 25 Years in Neuroendovascular Technologies that Improve Patient Lives PR Newswire ALISO VIEJO, Calif. , Sept. 29, 2022 /PRNewswire/ -- MicroVention, Inc., a global neurovascular company and a wholly owned subsidiary of Terumo Corpo...

The following slide deck was published by Terumo Corporation in conjunction with their 2022 Q1 earnings call. For further details see: Terumo Corporation 2022 Q1 - Results - Earnings Call Presentation

Terumo Corporation (TRUMF) Q1 202 Earnings Conference Call August 9, 2022 4:00 A.M. ET Company Participants Naoki Muto - Chief Accounting and Financial Officer Conference Call Participants Presentation Naoki Muto I am the CAFO, Muto. I will no...

MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide Catheter PR Newswire ALISO VIEJO, Calif. , April 20, 2022 /PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, annou...

Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture Terumo Establishes Group-wide 'DE&I Philosophy' to Further Cultivate a Diverse, Equitable and Inclusive Culture PR Newswire TOKYO , Feb. 28,&#x...

Terumo and Corazon Sign Collaboration and Co-Marketing Agreement - Alignment signals recognition of Terumo Health Outcomes' proprietary ePRISM® technology using precision medicine to improve outcomes for cardiac patients and Corazon accreditation as a means to monitor and r...

MicroVention Announces First U.S. Patient Treated with FRED™ X™ Flow Diverter Featuring X Technology PR Newswire ALISO VIEJO, Calif. , Feb. 22, 2022 /PRNewswire/ -- MicroVention, Inc., a subsidiary of Terumo and a global neurovascular company, annou...

Terumo Corporation (TRUMF) Q3 2021 Earnings Conference Call February 10,2022, 6:00 AM ET Company Participants Naoki Muto – Chief Accounting & Financial Officer Conference Call Participants Presentation Naoki Muto I'm the CFO, Muto. I will now explain the third quarter results for t...